Our corporate headquarters are located at 23515 NE Novelty Hill Road, Suite B221 #125 Redmond, WA 98053.
The Company was founded in 2018.
The Company is incorporated in Delaware.
Eliem Therapeutics completed its IPO on August 10, 2021 at a price of $12.50.
The Company’s fiscal year ends December 31st.
Our common stock is listed on the NASDAQ Market under the symbol “ELYM”.
The transfer agent and registrar for the common stock of Eliem Therapeutics’ stock is American Stock Transfer & Trust Company, LLC
6201 15th Ave,
Brooklyn, NY 11219 (800) 937-5449
For questions about your stock please contact our transfer agent, American Stock Transfer & Trust Company, LLC
To change the address on your shareholder account you must send both your old and new addresses to our transfer agent, American Stock Transfer & Trust Company, LLC 6201 15th Ave, Brooklyn, NY 11219
To transfer stock or replace a lost stock certificate, contact our transfer agent, American Stock Transfer & Trust Company, LLC
The auditor for Eliem Therapeutics is PricewaterhouseCoopers located in Seattle, WA.
Legal counsel for Eliem Therapeutics is Cooley LLP located in Seattle, WA.
To find out more about Eliem Therapeutics visit our webpage at www.eliemtx.com.
Eliem Therapeutics press release archive can be viewed under the “Press Releases” section of the “Investors” page and financial reports are available under the “Financials & Filings” section located at our website: www.eliemtx.com.
Eliem Therapeutics SEC Filings can be found on www.sec.gov and are also available under the “Financials & Filings” section of the “Investors” page located at our website www.eliemtx.com.
For a list of the Executive Management team and Board of Directors please visit the “Team” tab of our website.